• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to Letter to the Editor titled, "Does Evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?" by Christian Saleh.

作者信息

Wiegman Albert, Raal Frederick J, Bhatia Ajay K

机构信息

Department of Paediatrics, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Division of Endocrinology and Metabolism, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

Eur J Prev Cardiol. 2025 Jan 11. doi: 10.1093/eurjpc/zwaf005.

DOI:10.1093/eurjpc/zwaf005
PMID:39797906
Abstract
摘要

相似文献

1
Response to Letter to the Editor titled, "Does Evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?" by Christian Saleh.对克里斯蒂安·萨利赫所写的致编辑信的回复，信的标题为“依洛尤单抗治疗是否能降低杂合子家族性高胆固醇血症儿科患者的颈动脉内膜中层厚度？”
Eur J Prev Cardiol. 2025 Jan 11. doi: 10.1093/eurjpc/zwaf005.
2
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia.依洛尤单抗治疗可降低杂合子家族性高胆固醇血症儿科患者的颈动脉内膜中层厚度。
Eur J Prev Cardiol. 2024 Nov 12. doi: 10.1093/eurjpc/zwae369.
3
Does evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?依洛尤单抗治疗对杂合子家族性高胆固醇血症患儿的颈动脉内膜中层厚度有降低作用吗？
Eur J Prev Cardiol. 2024 Dec 18. doi: 10.1093/eurjpc/zwae391.
4
Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study.脂蛋白(a)与荷兰家族性高胆固醇血症患儿颈动脉内中膜厚度：一项 20 年随访研究。
Lancet Diabetes Endocrinol. 2023 Sep;11(9):667-674. doi: 10.1016/S2213-8587(23)00156-0. Epub 2023 Jul 21.
5
Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia.家族性高胆固醇血症杂合子儿童的动脉内膜中层厚度
Lancet. 2004 Jan 31;363(9406):369-70. doi: 10.1016/S0140-6736(04)15467-6.
6
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT.接受依洛尤单抗治疗 80 周的杂合子家族性高胆固醇血症儿科患者（HAUSER-OLE）：HAUSER-RCT 的单臂、多中心、开放标签扩展研究。
Lancet Diabetes Endocrinol. 2022 Oct;10(10):732-740. doi: 10.1016/S2213-8587(22)00221-2. Epub 2022 Sep 5.
7
Response to Letter to the Editors of Christian Saleh: Continuous positive airway pressure therapy, obstructive sleep apnea-hypopnea syndrome and atherosclerosis: the effect of timing of carotid intima-media thickness.对致《克里斯蒂安·萨利赫编辑信件》的回复：持续气道正压通气治疗、阻塞性睡眠呼吸暂停低通气综合征与动脉粥样硬化：颈动脉内膜中层厚度测量时机的影响
Sleep Breath. 2025 Mar 8;29(1):121. doi: 10.1007/s11325-025-03294-3.
8
Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial.来洛西贝肽和依洛尤单抗通过抑制前蛋白转化酶枯草溶菌素9治疗纯合子家族性高胆固醇血症（LIBerate-HoFH）：一项3期随机开放标签交叉非劣效性试验
Lancet Diabetes Endocrinol. 2025 Mar;13(3):178-187. doi: 10.1016/S2213-8587(24)00313-9. Epub 2025 Jan 24.
9
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment.依洛尤单抗治疗儿科杂合子家族性高胆固醇血症：80 周开放标签扩展治疗期间的认知功能。
Eur J Prev Cardiol. 2024 Feb 15;31(3):302-310. doi: 10.1093/eurjpc/zwad332.
10
Effects of Evolocumab on Carotid Intima-Media Thickness and Clinical Parameters in Patients Taking a Statin.依洛尤单抗对服用他汀类药物患者颈动脉内膜中层厚度及临床参数的影响。
J Clin Med. 2020 Jul 16;9(7):2256. doi: 10.3390/jcm9072256.